logo
Twitter
Discord
Email
logo
Aflac Incorporated

Aflac Incorporated

NYSE•AFL
CEO: Mr. Daniel Paul Amos
Sector: Financial Services
Industry: Insurance - Life
Listing Date: 1980-03-17
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Contact Information
1932 Wynnton Road, Columbus, GA, 31999, United States
706-323-3431
www.aflac.com
Market Cap
$58.57B
P/E (TTM)
13.9
14.8
Dividend Yield
2.1%
52W High
$115.84
52W Low
$96.95
52W Range
66%
Rank16Top 3.7%
6.5
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Strong • 6.5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$4.79B+57.92%
4-Quarter Trend

EPS

$3.09-1917.65%
4-Quarter Trend

FCF

$1.25B-1.42%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Strong Third Quarter Earnings Net earnings $1.64B for Q3 2025, reversing prior year loss of $(93)M; diluted EPS $3.08.
Investment Gains Rebound Net investment gains $275M in Q3 2025, a significant swing from $1.41B net losses in Q3 2024.
Increased Shareholder Payout Cash dividends per share increased to $0.58 for Q3 2025, up from $0.50 in Q3 2024.
Aggressive Capital Return Repurchased $2.7B of common stock during NME 2025; 121.6M shares remain authorized for buyback.

Risk Factors

Nine Month Earnings Decline NME net earnings fell to $2.27B in 2025 from $3.54B in 2024, driven by investment losses.
Unquantified Cyber Incident Loss Investigation ongoing regarding data exfiltration from U.S. network access; potential loss impact remains unestimated.
Reliance on Unobservable Inputs Significant Level 3 fair value inputs used for commercial mortgage loans, increasing valuation uncertainty.
Foreign Currency Translation Risk Yen/dollar exchange rate fluctuations significantly affect reported USD earnings and investment income translation.

Outlook

Japan Sales Portfolio Focus Expect continued need for third sector products; promoting digital sales tools for customer acquisition and policy completion.
Maintaining High Liquidity Levels Plans to sustain elevated cash levels to address hedge collateral needs and mitigate long-term yen weakening risks.
New Liquidity Facility Expansion Expanded liquidity sources by entering two new Delaware Trust facility agreements totaling $2.0B capacity.
Preparing for ESR Reporting Aflac Japan preparing for new Economic Solvency Ratio (ESR) reporting requirements effective March 31, 2026.

Peer Comparison

Revenue (TTM)

MetLife, Inc.MET
$71.29B
-0.1%
Prudential Financial, Inc.PRU
$57.91B
-13.2%
Manulife Financial CorporationMFC
$49.05B
+41.4%

Gross Margin (Latest Quarter)

Brighthouse Financial, Inc.BHF
51.1%
+19.2pp
Aflac IncorporatedAFL
43.9%
+28.1pp
Primerica, Inc.PRI
43.5%
-1.0pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
MFC$62.97B14.911.5%1.3%
AFL$58.57B13.915.4%7.1%
MET$50.58B13.313.8%2.8%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-4.5%
Flat Growth
4Q Net Income CAGR
-4.8%
Stable Profitability
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Feb 4, 2026
|
EPS:$1.72
|
Revenue:$4.42B
Reports
All Years
  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 5, 2025|
    Revenue: $4.79B+57.9%
    |
    EPS: $3.09-1917.6%
    Beat
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 5, 2025|
    Revenue: $4.22B-18.2%
    |
    EPS: $1.12-64.0%
    Miss
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 7, 2025|
    Revenue: $3.45B-36.5%
    |
    EPS: $0.05-98.4%
    Miss
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 26, 2025|
    Revenue: $19.13B+1.5%
    |
    EPS: $9.68+23.9%
    Beat
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 1, 2024|
    Revenue: $3.04B-39.7%
    |
    EPS: $-0.17-106.4%
    Miss
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 1, 2024|
    Revenue: $5.16B-0.3%
    |
    EPS: $3.11+14.3%
    Beat
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 2, 2024|
    Revenue: $5.44B+12.5%
    |
    EPS: $3.27+68.6%
    Beat
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 22, 2024|
    Revenue: $18.84B-1.6%
    |
    EPS: $7.81+12.2%
    Beat